ConductScience.org, home

Paper36498656

Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.

Bussolati E and 11 others. J Clin Med, 2022. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients. Papers, record 36498656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36498656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.
PubMed
Journal
J Clin Med
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2022-12-21
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bussolati EEnrico
2Cultrera RRosariohttps://orcid.org/0000-0002-7440-6447
3Quaranta AAlessandra
4Cricca VValentinahttps://orcid.org/0000-0002-6207-0253
5Marangoni EElisabetta
6La Rosa RRiccardohttps://orcid.org/0000-0001-6636-960X
7Bertacchini SSara
8Bellonzi AAlessandra
9Ragazzi RRiccardohttps://orcid.org/0000-0002-9736-1966
10Volta CACarlo Albertohttps://orcid.org/0000-0003-3533-6121
11Spadaro SSavinohttps://orcid.org/0000-0001-5027-5318
12Scaramuzzo GGaetanohttps://orcid.org/0000-0001-9739-4082

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132250385Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA2020https://conductscience.org/library/papers/32250385PubMed
232031570Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.JAMA2020https://conductscience.org/library/papers/32031570PubMed
333506379COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.Intensive Care Med2021https://conductscience.org/library/papers/33506379PubMed
430679153Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.Ann Rheum Dis2019https://conductscience.org/library/papers/30679153PubMed
533207271Predictors and outcomes of healthcare-associated infections in COVID-19 patients.Int J Infect Dis2021https://conductscience.org/library/papers/33207271PubMed
633195334IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.Front Med (Lausanne)2020https://conductscience.org/library/papers/33195334PubMed
719952319International study of the prevalence and outcomes of infection in intensive care units.JAMA2009https://conductscience.org/library/papers/19952319PubMed
820486854Suction regulators: a potential vector for hospital-acquired pathogens.Infect Control Hosp Epidemiol2010https://conductscience.org/library/papers/20486854PubMed
932356696Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM.Ann Am Thorac Soc2020https://conductscience.org/library/papers/32356696PubMed
1034088341The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study.Antimicrob Resist Infect Control2021https://conductscience.org/library/papers/34088341PubMed
1135625339An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs.Antibiotics (Basel)2022https://conductscience.org/library/papers/35625339PubMed
1233845927Hospital-acquired infections among adult patients admitted for coronavirus disease 2019 (COVID-19).Infect Control Hosp Epidemiol2022https://conductscience.org/library/papers/33845927PubMed
1332217835Clinical and immunological features of severe and moderate coronavirus disease 2019.J Clin Invest2020https://conductscience.org/library/papers/32217835PubMed
1428562638Every antibiotic, every day: Maximizing the impact of prospective audit and feedback on total antibiotic use.PLoS One2017https://conductscience.org/library/papers/28562638PubMed
1533602361
Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts.
Infect Control Hosp Epidemiol2022https://conductscience.org/library/papers/33602361PubMed
1632943328SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.J Microbiol Immunol Infect2021https://conductscience.org/library/papers/32943328PubMed
1712163791Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.Crit Care Med2002https://conductscience.org/library/papers/12163791PubMed
1833857475Hospital-Acquired Infections in Critically Ill Patients With COVID-19.Chest2021https://conductscience.org/library/papers/33857475PubMed
1932892033The potential impact of enhanced hygienic measures during the COVID-19 outbreak on hospital-acquired infections: A pragmatic study in neurological units.J Neurol Sci2020https://conductscience.org/library/papers/32892033PubMed
2033157180Unintended consequences of infection prevention and control measures during COVID-19 pandemic.Am J Infect Control2021https://conductscience.org/library/papers/33157180PubMed

See all 34 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41320199COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study.BMJ Glob Health2025https://conductscience.org/library/papers/41320199PubMed
38535561Total Infectome Characterization of Respiratory Infections during the 2022-23 COVID-19 Outbreak in China Revealed Extensive Coinfections with Links to SARS-CoV-2 Status, Age, and Disease Severity.Pathogens2024https://conductscience.org/library/papers/38535561PubMed
38391578Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19-A Prospective Monocentric Cohort Study.Antibiotics (Basel)2024https://conductscience.org/library/papers/38391578PubMed
37110369Multidrug Resistance in Critically Ill Patients: An Unresolved Issue.Microorganisms2023https://conductscience.org/library/papers/37110369PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36498656

GET https://conductscience.org/api/papers/v1/36498656/references?page=2